
- BioPharm International's BP Elements, May 2023
- Volume 2
- Issue 5
BioChain Institute Extends Spatial Multiomics Services
BioChain has reached partnerships with NanoString and 10x Genomics to extend its spatial multiomics services.
BioChain Institute, a supplier of biosample products and services, recently announced the extension of its spatial multiomics services via partnerships with NanoString Technologies and 10X Genomics. NanoString is a biotechnology company specializing in technology and translational research solutions, while 10X Genomics is a biotechnology company focused on gene sequencing technology.
According to an April 18, 2023 press release, spatial profiling is a technique that reveals the spatial context of RNA and proteins in tissue. BioChain spatial profiling technology uses a three-step process: selecting tissue samples, working with spatial biology scientists to determine which spatial path to use, and running the customized spatial process.
“Our partnerships, combined with our in-house services, make us a full-service provider of spatial biology services,” said Vidyodhaya Sundaram, vice-president of Business Development, BioChain, in the release. “With the technologies now available from BioChain, you can spatially resolve the entire transcriptome or high-plex protein across your tissue sample.”
“Our technology’s advantages include its high multiplexing ability, low hands-on time, and a straightforward procedure,” continued Sundaram. “Our goal is to bring this specialized technology to any researcher or biomedical professional who wants to use it.”
Source: BioChain Institute
Articles in this issue
over 2 years ago
Ramping Up Nucleic Acid Therapy Developmentover 2 years ago
Cryo/Lyoprotectants Quality Challengesalmost 3 years ago
New Expansion for BalanCD CHO Media Platform Portfolio for BioprocessingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.




